These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2939951)

  • 61. Pharmacologic regression of cardiac hypertrophy in experimental hypertension.
    Pfeffer MA; Pfeffer JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S865-9. PubMed ID: 6084141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of cardiac status in hypertensive patients.
    Tarazi RC; Fouad FM
    J Hypertens Suppl; 1985 Nov; 3(2):S27-31. PubMed ID: 2935603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.
    Borhani NO
    Am J Cardiol; 1987 Dec; 60(17):13I-18I. PubMed ID: 2961245
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is reversal of left ventricular hypertrophy in hypertension beneficial?
    Frohlich ED
    Hypertension; 1991 Sep; 18(3 Suppl):I133-8. PubMed ID: 1832414
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of hypertension and cardiovascular complications].
    Delahaye JP; Pillot M; Delahaye F; Dubost A
    Arch Mal Coeur Vaiss; 1991 Sep; 84 Spec No 3():117-21. PubMed ID: 1683221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Left ventricular hypertrophy and myocardial ischemia (coronary atherosclerosis excluded)].
    Bounhoure JP; Galinier M
    Arch Mal Coeur Vaiss; 1991 Sep; 84 Spec No 3():107-10. PubMed ID: 1835363
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pressure overload-induced cardiac hypertrophy with and without dilation.
    Randhawa AK; Singal PK
    J Am Coll Cardiol; 1992 Dec; 20(7):1569-75. PubMed ID: 1452932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
    Oh KS; Lee JH; Yi KY; Lim CJ; Park BK; Seo HW; Lee BH
    Eur J Pharmacol; 2017 Mar; 799():94-102. PubMed ID: 28163023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of hypertension and cardiovascular risk.
    Hollenberg NK
    Am J Med; 1991 Feb; 90(2A):2S-6S. PubMed ID: 1671628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypertension: left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Ketelhut R; Messerli FH
    Prim Care; 1991 Sep; 18(3):577-92. PubMed ID: 1835104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Left ventricular hypertrophy: further evidence of risk.
    Frohlich ED
    J Am Coll Cardiol; 1991 Nov; 18(5):1295-6. PubMed ID: 1833431
    [No Abstract]   [Full Text] [Related]  

  • 74. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antihypertensive therapy and coronary prevention.
    Klein WW
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S23-7. PubMed ID: 1707111
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.
    Tarazi RC
    Am J Med; 1983 Sep; 75(3A):80-6. PubMed ID: 6226199
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Left ventricular hypertrophy. A crucial target for antihypertensive therapy.
    Messerli FH
    Postgrad Med; 1990 Jul; 88(1):127-8, 131, 134. PubMed ID: 2142278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determinants of ventricular ectopy in hypertensive cardiac hypertrophy.
    Schmieder RE; Messerli FH
    Am Heart J; 1992 Jan; 123(1):89-95. PubMed ID: 1530898
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and regression of left ventricular hypertrophy.
    Panidis IP; Kotler MN; Ren JF; Mintz GS; Ross J; Kalman P
    J Am Coll Cardiol; 1984 May; 3(5):1309-20. PubMed ID: 6231335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.